Slingshot members are tracking this event:
Phase 1/2 presentation of Jazz Pharma's (JAZZ) CPX-351 in Acute myeloid leukemia expected at ASCO May 31, 2019, 3:45 p.m. CT
Slingshot Insights Explained
Jun 01, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Cpx-351, Asco 2019, Acute Myeloid Leukemia, Aml